Summary of findings 3. Ultrasound guidance versus landmark method for peripheral venous cannulation in adults classed as easy.
Patient or population: adults undergoing peripheral venous cannulation classed as easya Settings: emergency department Intervention: USG Comparison: LM | ||||||
Outcomes | Anticipated absolute effects* (95% CI) | Relative effect (95% CI) | No. of participants (studies) | Certainty of the evidence (GRADE) | Comments | |
Risk with LM | Risk with USG | |||||
First‐pass success of cannulation Follow‐up: immediately after the procedure |
966 per 1000 | 859 per 1000 (821 to 908) | RR 0.89 (0.85 to 0.94) | 596 (1 RCT) |
⊕⊕⊕⊕ High | |
Overall success of cannulation Follow‐up: immediately after the procedure |
See comment | ‐ | ‐ | ‐ | ‐ | None of the studies included easy participants |
Pain NRS: from 0 to 10, where 10 is maximum pain Follow‐up: immediately after the procedure |
The mean pain score was 2.30 | MD 0.60 higher (0.17 higher to 1.03 higher) | 596 (1 RCT) |
⊕⊕⊕⊝
Moderateb |
||
Procedure time for first‐pass cannulation (seconds) Follow‐up: immediately after the procedure |
The mean procedure time for first‐pass cannulation was 89.7 seconds | MD 94.8 seconds longer (81.2 longer to 108.5 longer) | 596 (1 RCT) |
⊕⊕⊕⊕ High | ||
Number of cannulation attempts Follow‐up: immediately after the procedure |
See comment | ‐ | ‐ | ‐ | ‐ | None of the studies included easy participants |
Patient satisfaction NRS from 0 to 10 or 4‐step Likert scale The higher the score, the higher the level of satisfaction Follow‐up: immediately after the procedure |
See comment | ‐ | ‐ | ‐ | ‐ | None of the studies included easy participants |
Overall complications Follow‐up: immediately after the procedure |
17 per 1000 | 43 per 1000 (15 to 118) | RR 2.48 (0.90 to 6.87) | 596 (1 RCT) | ⊕⊕⊕⊝ Moderatec | |
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: confidence interval; LM: landmark; NRS: numeric rating scale; RCTs: randomised controlled trials; RR: risk ratio; USG: ultrasound guidance | ||||||
GRADE Working Group grades of evidence High certainty: We are very confident that the true effect lies close to that of the estimate of the effect. Moderate certainty: We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low certainty: Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. Very low certainty: We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. |
aParticipants were classified according to the original studies' definitions. bWe downgraded by one level to moderate certainty due to risk of bias concerns (lack of blinding of the outcome assessors). cWe downgraded by one level to moderate certainty due to imprecision.